Insider Trading activities of Viropharma Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viropharma Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viropharma Inc since year 2005. Table 2 shows the detailed insider transactions of Viropharma Inc since 2005. The reporting company's ticker symbol is VPHM. The reporting company's CIK number is 946840.
The total value of stock buying since 2005 is $139,402,362.
The total value of stock sales since 2005 is $117,576,403.
The total value of stock option exercises since 2005 is $9,554,588.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Viropharma Inc (VPHM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-02 0 $0 0 $0 10,000 $17,700
2012-12 2,500 $62,675 180,499 $4,326,534 120,499 $725,336
2012-11 0 $0 163,418 $4,029,094 171,418 $1,099,303
2012-06 0 $0 10,000 $200,430 10,000 $34,200
2012-03 0 $0 381,350 $12,229,915 417,531 $2,626,048
2012-01 0 $0 0 $0 10,000 $279,100
2011-12 400,666 $10,933,373 100,000 $2,444,980 133,805 $1,016,251
2011-11 0 $0 200,058 $4,429,574 200,058 $1,100,820
2011-10 742,183 $13,191,018 20,495 $418,548 20,495 $64,354
2011-09 1,113,810 $19,955,010 0 $0 0 $0
2011-08 289,161 $4,771,473 20,000 $400,000 20,000 $400,000
2011-03 0 $0 73,641 $1,356,715 73,641 $373,238
2010-12 0 $0 19,500 $323,857 37,000 $335,848
2010-11 0 $0 6,359 $108,357 6,359 $18,695
2010-09 0 $0 30,000 $397,926 30,000 $55,199
2010-05 20,000 $244,300 1,806,692 $22,854,086 15,000 $180,000
2010-04 4,484,008 $57,861,813 0 $0 0 $0
2009-05 1,198,690 $6,848,933 0 $0 0 $0
2009-03 30,000 $121,500 0 $0 0 $0
2009-02 43,300 $185,085 0 $0 0 $0
2009-01 0 $0 0 $0 45,000 $523,124
2008-11 8,000 $102,160 345,677 $4,227,460 45,000 $144,450
2008-09 0 $0 27,553 $392,993 15,384 $48,305
2008-03 167,278 $1,444,979 0 $0 0 $0
2008-02 0 $0 0 $0 36,900 $99,999
2008-01 502,883 $4,442,434 0 $0 0 $0
2007-11 2,392,787 $17,783,101 0 $0 0 $0
2007-09 0 $0 0 $0 39,477 $94,744
2007-08 41,120 $334,962 0 $0 0 $0
2007-04 0 $0 1,529,314 $23,493,557 0 $0
2007-02 0 $0 10,000 $180,189 10,000 $151,250
2007-01 0 $0 5,000 $82,500 5,000 $75,624
2006-12 0 $0 7,000 $104,979 7,000 $91,000
2006-09 6,000 $73,596 0 $0 0 $0
2006-05 20,100 $195,683 0 $0 0 $0
2006-02 0 $0 1,678,430 $35,574,709 0 $0
2005-06 24,000 $135,875 0 $0 0 $0
2005-05 232,834 $714,392 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Viropharma Inc insiders (VPHM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-02-20 Brooke Paul A (Director) Option Ex 10,000 1.77 17,700
2012-12-27 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 10,000 1.84 18,400
2012-12-24 Broom Colin Md (VP & Chief Scientific Officer) Sale 17,500 22.53 394,310
2012-12-24 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 17,500 1.84 32,200
2012-12-13 Brooke Paul A (Director) Sale 60,000 23.87 1,431,960
2012-12-10 Broom Colin Md (VP & Chief Scientific Officer) Sale 74,999 24.07 1,805,000
2012-12-10 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 74,999 8.24 618,216
2012-12-03 Wolf John Peter Iii (VP, General Counsel) Sale 18,000 24.85 447,264
2012-12-03 Wolf John Peter Iii (VP, General Counsel) Option Ex 18,000 3.14 56,520
2012-12-03 Claypool William D Md (Director) Sale 10,000 24.80 248,000
2012-12-03 Dougherty Michael R (Director) Buy 2,500 25.07 62,675
2012-11-30 Glaser Robert (Director) Sale 30,000 24.78 743,370
2012-11-30 Glaser Robert (Director) Option Ex 30,000 11.58 347,250
2012-11-28 Claypool William D Md (Director) Sale 17,500 24.22 423,885
2012-11-28 Claypool William D Md (Director) Option Ex 17,500 8.22 143,850
2012-11-28 Milano Vincent (President and CEO) Option Ex 18,000 3.55 63,900
2012-11-13 Claypool William D Md (Director) Sale 22,500 24.92 560,812
2012-11-13 Claypool William D Md (Director) Option Ex 22,500 7.42 166,837
2012-11-08 Milano Vincent (President and CEO) Sale 83,418 24.54 2,047,327
2012-11-08 Milano Vincent (President and CEO) Option Ex 83,418 4.52 377,466
2012-11-02 Claypool William D Md (Director) Sale 10,000 25.37 253,700
2012-06-11 Claypool William D Md (Director) Sale 10,000 20.04 200,430
2012-06-11 Claypool William D Md (Director) Option Ex 10,000 3.42 34,200
2012-03-23 Pietrusko Robert (VP, Regulatory & Quality) Sale 20,000 30.00 600,000
2012-03-23 Pietrusko Robert (VP, Regulatory & Quality) Option Ex 20,000 8.86 177,200
2012-03-09 Fletcher Robert C. (V.P., Business Development) Sale 32,000 29.66 948,960
2012-03-09 Fletcher Robert C. (V.P., Business Development) Option Ex 32,000 3.19 102,080
2012-03-09 Morris Richard Steven (Chief Accounting Officer) Sale 1,300 29.71 38,617
2012-03-09 Morris Richard Steven (Chief Accounting Officer) Option Ex 1,300 7.05 9,165
2012-03-09 Soland Daniel B (VP, Chief Operating Officer) Option Ex 48,293 12.88 622,158
2012-03-07 Rowland Charles A Jr (VP, Chief Financial Officer) Option Ex 30,638 12.73 390,021
2012-03-05 Morris Richard Steven (Chief Accounting Officer) Sale 5,300 33.01 174,953
2012-03-05 Morris Richard Steven (Chief Accounting Officer) Option Ex 5,300 6.48 34,344
2012-03-05 Doyle Thomas F (VP Strategic Initiatives) Sale 210,000 32.48 6,820,169
2012-03-05 Doyle Thomas F (VP Strategic Initiatives) Option Ex 210,000 3.18 667,380
2012-03-01 Rowland Charles A Jr (VP, Chief Financial Officer) Sale 82,750 32.12 2,657,516
2012-03-01 Rowland Charles A Jr (VP, Chief Financial Officer) Option Ex 70,000 8.91 623,700
2012-03-01 Soland Daniel B (VP, Chief Operating Officer) Sale 30,000 32.99 989,700
2012-01-04 Milano Vincent (President and CEO) Option Ex 10,000 27.91 279,100
2011-12-29 Fletcher Robert C. (V.P., Business Development) Option Ex 1,300 22.99 29,886
2011-12-23 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 17,500 1.84 32,200
2011-12-14 Broom Colin Md (VP & Chief Scientific Officer) Sale 50,000 25.34 1,266,750
2011-12-14 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 50,000 8.71 435,500
2011-12-14 Baker Felix (10% Owner) Buy 58,394 27.29 1,593,455
2011-12-14 Baker Julian (10% Owner) Buy 291,706 27.29 7,960,073
2011-12-13 Broom Colin Md (VP & Chief Scientific Officer) Sale 22,330 23.50 524,755
2011-12-13 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 22,330 7.05 157,426
2011-12-12 Broom Colin Md (VP & Chief Scientific Officer) Sale 17,670 23.50 415,315
2011-12-12 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 17,670 7.05 124,573
2011-12-05 Milano Vincent (President and CEO) Option Ex 15,005 2.34 35,066
2011-12-01 Doyle Thomas F (VP Strategic Initiatives) Sale 10,000 23.82 238,160
2011-12-01 Doyle Thomas F (VP Strategic Initiatives) Option Ex 10,000 20.16 201,600
2011-11-30 Pietrusko Robert (VP, Regulatory & Quality) Sale 20,000 24.00 480,000
2011-11-30 Pietrusko Robert (VP, Regulatory & Quality) Option Ex 20,000 9.99 199,800
2011-11-28 Pietrusko Robert (VP, Regulatory & Quality) Sale 19,000 23.00 437,000
2011-11-28 Pietrusko Robert (VP, Regulatory & Quality) Option Ex 19,000 9.99 189,810
2011-11-28 Glaser Robert (Director) Sale 5,000 23.00 115,000
2011-11-28 Glaser Robert (Director) Option Ex 5,000 3.00 15,000
2011-11-23 Pietrusko Robert (VP, Regulatory & Quality) Sale 1,000 23.00 23,000
2011-11-23 Pietrusko Robert (VP, Regulatory & Quality) Option Ex 1,000 9.99 9,990
2011-11-21 Milano Vincent (President and CEO) Sale 76,687 22.53 1,727,451
2011-11-21 Milano Vincent (President and CEO) Option Ex 76,687 3.19 244,631
2011-11-16 Morris Richard Steven (Chief Accounting Officer) Sale 2,000 22.59 45,180
2011-11-16 Morris Richard Steven (Chief Accounting Officer) Option Ex 2,000 20.28 40,560
2011-11-14 Pietrusko Robert (VP, Regulatory & Quality) Sale 20,000 22.00 440,000
2011-11-14 Pietrusko Robert (VP, Regulatory & Quality) Option Ex 20,000 8.86 177,200
2011-11-07 Wolf John Peter Iii (VP, General Counsel) Sale 12,250 21.08 258,193
2011-11-07 Wolf John Peter Iii (VP, General Counsel) Option Ex 12,250 2.44 29,890
2011-11-07 Broom Colin Md (VP & Chief Scientific Officer) Sale 20,000 21.00 420,100
2011-11-07 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 20,000 5.91 118,200
2011-11-01 Broom Colin Md (VP & Chief Scientific Officer) Sale 24,121 20.05 483,650
2011-11-01 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 24,121 3.14 75,739
2011-10-31 Broom Colin Md (VP & Chief Scientific Officer) Sale 20,495 20.42 418,548
2011-10-31 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 20,495 3.14 64,354
2011-10-05 Baker Felix (10% Owner) Buy 22,295 18.18 405,389
2011-10-05 Baker Julian (10% Owner) Buy 145,763 18.18 2,650,408
2011-10-04 Baker Felix (10% Owner) Buy 4,416 17.48 77,173
2011-10-04 Baker Julian (10% Owner) Buy 45,584 17.48 796,625
2011-10-03 Baker Julian (10% Owner) Buy 516,203 17.66 9,118,725
2011-09-30 Baker Felix (10% Owner) Buy 25,222 18.14 457,425
2011-09-30 Baker Julian (10% Owner) Buy 131,978 18.14 2,393,553
2011-09-29 Baker Felix (10% Owner) Buy 42,502 17.98 764,313
2011-09-29 Baker Julian (10% Owner) Buy 249,915 17.98 4,494,221
2011-09-26 Baker Felix (10% Owner) Buy 33,068 18.13 599,455
2011-09-26 Baker Julian (10% Owner) Buy 159,641 18.13 2,893,972
2011-09-23 Baker Felix (10% Owner) Buy 45,661 17.70 808,245
2011-09-23 Baker Julian (10% Owner) Buy 224,769 17.70 3,978,636
2011-09-22 Baker Felix (10% Owner) Buy 11,849 17.43 206,479
2011-09-22 Baker Julian (10% Owner) Buy 63,151 17.43 1,100,469
2011-08-31 Pietrusko Robert (VP, Regulatory & Quality) Sale 20,000 20.00 400,000
2011-08-31 Pietrusko Robert (VP, Regulatory & Quality) Option Ex 20,000 20.00 400,000
2011-08-23 Baker Felix (10% Owner) Buy 5,971 16.97 101,350
2011-08-23 Baker Julian (10% Owner) Buy 32,704 16.97 555,117
2011-08-10 Baker Felix (10% Owner) Buy 5,934 16.43 97,477
2011-08-10 Baker Julian (10% Owner) Buy 244,049 16.43 4,008,992
2011-03-14 Rowland Charles A Jr (VP, Chief Financial Officer) Sale 35,000 18.56 649,740
2011-03-14 Rowland Charles A Jr (VP, Chief Financial Officer) Option Ex 35,000 7.38 258,475
2011-03-03 Claypool William D Md (Director) Sale 38,641 18.30 706,975
2011-03-03 Claypool William D Md (Director) Option Ex 38,641 2.97 114,763
2010-12-31 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 2,500 1.84 4,600
2010-12-14 Glaser Robert (Director) Sale 5,000 16.75 83,750
2010-12-13 Doyle Thomas F (VP Strategic Initiatives) Option Ex 10,000 14.12 141,250
2010-12-13 Milano Vincent (President and CEO) Option Ex 10,000 14.12 141,250
2010-12-09 Morris Richard Steven (Chief Accounting Officer) Sale 13,300 16.56 220,247
2010-12-09 Morris Richard Steven (Chief Accounting Officer) Option Ex 13,300 3.34 44,488
2010-12-08 Morris Richard Steven (Chief Accounting Officer) Sale 1,200 16.55 19,860
2010-12-08 Morris Richard Steven (Chief Accounting Officer) Option Ex 1,200 3.55 4,260
2010-11-09 Claypool William D Md (Director) Sale 6,359 17.04 108,357
2010-11-09 Claypool William D Md (Director) Option Ex 6,359 2.94 18,695
2010-09-13 Broom Colin Md (VP & Chief Scientific Officer) Sale 5,060 13.28 67,171
2010-09-13 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 5,060 1.84 9,310
2010-09-10 Broom Colin Md (VP & Chief Scientific Officer) Sale 7,900 13.26 104,754
2010-09-10 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 7,900 1.84 14,536
2010-09-09 Broom Colin Md (VP & Chief Scientific Officer) Sale 17,040 13.26 226,001
2010-09-09 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 17,040 1.84 31,353
2010-05-27 Glaser Robert (Director) Sale 10,000 12.50 125,000
2010-05-27 Glaser Robert (Director) Option Ex 10,000 12.00 120,000
2010-05-10 Baker Felix (10% Owner) Sale 515,590 12.70 6,548,508
2010-05-07 Soland Daniel B (VP, Chief Operating Officer) Buy 10,000 11.91 119,100
2010-05-07 Baker Felix (10% Owner) Sale 109,044 12.46 1,358,469
2010-05-06 Soland Daniel B (VP, Chief Operating Officer) Buy 10,000 12.52 125,200
2010-05-06 Baker Felix (10% Owner) Sale 319,272 12.64 4,034,320
2010-04-30 Baker Felix (10% Owner) Buy 409,844 12.77 5,232,887
2010-04-30 Baker Julian (10% Owner) Buy 431,154 12.77 5,504,974
2010-04-29 Baker Felix (10% Owner) Buy 869,304 13.01 11,306,167
2010-04-29 Baker Julian (10% Owner) Buy 914,504 13.01 11,894,039
2010-04-28 Baker Felix (10% Owner) Buy 16,579 12.74 211,266
2010-04-28 Baker Julian (10% Owner) Buy 600,619 12.74 7,653,687
2009-05-21 Baker Felix (10% Owner) Buy 39,207 6.09 238,691
2009-05-21 Baker Julian (10% Owner) Buy 86 6.09 523
2009-05-19 Baker Felix (10% Owner) Buy 83,299 5.99 499,043
2009-05-19 Baker Julian (10% Owner) Buy 183 5.99 1,096
2009-05-18 Baker Felix (10% Owner) Buy 90,632 5.93 537,084
2009-05-18 Baker Julian (10% Owner) Buy 199 5.93 1,179
2009-05-13 Baker Felix (10% Owner) Buy 453,181 5.46 2,473,460
2009-05-13 Baker Julian (10% Owner) Buy 996 5.46 5,436
2009-05-11 Baker Felix (10% Owner) Buy 99,700 5.86 584,041
2009-05-08 Baker Felix (10% Owner) Buy 135,711 5.92 803,950
2009-05-07 Baker Felix (10% Owner) Buy 225,191 5.72 1,288,766
2009-03-12 Soland Daniel B (VP, Chief Operating Officer) Buy 30,000 4.05 121,500
2009-02-27 Claypool William D Md (Director) Buy 20,000 3.97 79,320
2009-02-27 Doyle Thomas F (VP Strategic Initiatives) Buy 5,000 3.94 19,700
2009-02-27 Milano Vincent (President and CEO) Buy 2,300 4.13 9,505
2009-02-26 Rowland Charles A Jr (VP, Chief Financial Officer) Buy 16,000 4.78 76,560
2009-01-09 Doyle Thomas F (VP Strategic Initiatives) Option Ex 22,500 11.62 261,562
2009-01-09 Milano Vincent (President and CEO) Option Ex 22,500 11.62 261,562
2008-11-10 De Rosen Michel (Director) Sale 7,747 12.30 95,288
2008-11-07 De Rosen Michel (Director) Sale 292,930 12.15 3,557,927
2008-11-03 Rowland Charles A Jr (VP, Chief Financial Officer) Buy 8,000 12.77 102,160
2008-11-03 Dougherty Michael R (Director) Sale 45,000 12.76 574,245
2008-11-03 Dougherty Michael R (Director) Option Ex 45,000 3.21 144,450
2008-09-12 Broom Colin Md (VP & Chief Scientific Officer) Sale 25,353 14.26 361,533
2008-09-12 Broom Colin Md (VP & Chief Scientific Officer) Option Ex 15,384 3.14 48,305
2008-09-11 Morris Richard Steven (Chief Accounting Officer) Sale 2,200 14.30 31,460
2008-03-17 Baker Felix (10% Owner) Buy 7,834 8.14 63,728
2008-03-14 Baker Felix (10% Owner) Buy 5,000 8.66 43,322
2008-03-13 Baker Felix (10% Owner) Buy 70,884 8.69 616,121
2008-02-13 De Rosen Michel (Chief Executive Officer) Option Ex 36,900 2.71 99,999
2008-01-09 Baker Felix (10% Owner) Buy 102,178 8.95 914,286
2008-01-08 Baker Felix (10% Owner) Buy 149,500 8.76 1,309,020
2007-11-09 Baker Felix (10% Owner) Buy 285,000 7.63 2,174,549
2007-11-08 Baker Felix (10% Owner) Buy 500,000 7.43 3,716,997
2007-11-07 Soland Daniel B (VP, Chief Commercial Officer) Buy 10,000 7.26 72,600
2007-11-07 Baker Felix (10% Owner) Buy 400,000 7.27 2,909,597
2007-11-01 Soland Daniel B (VP, Chief Commercial Officer) Buy 15,000 8.31 124,650
2007-09-04 De Rosen Michel (Chief Executive Officer) Option Ex 39,477 2.40 94,744
2007-08-16 Soland Daniel B (VP, Chief Commercial Officer) Buy 15,000 8.00 120,000
2007-08-16 Milano Vincent (VP, COO & CFO) Buy 4,000 8.15 32,612
2007-08-16 De Rosen Michel (Chief Executive Officer) Buy 12,120 8.17 99,020
2007-08-15 Claypool William D Md (Director) Buy 10,000 8.33 83,330
2007-04-17 Baker Felix (10% Owner) Sale 181,569 15.44 2,803,424
2007-04-16 Baker Felix (10% Owner) Sale 87,000 15.49 1,347,627
2007-04-13 Baker Felix (10% Owner) Sale 503,485 15.31 7,709,360
2007-02-07 Glaser Robert (Director) Sale 10,000 18.02 180,189
2007-02-07 Glaser Robert (Director) Option Ex 10,000 15.12 151,250
2007-01-30 Glaser Robert (Director) Sale 2,500 17.00 42,500
2007-01-30 Glaser Robert (Director) Option Ex 2,500 15.12 37,812
2007-01-25 Glaser Robert (Director) Sale 2,500 16.00 40,000
2007-01-25 Glaser Robert (Director) Option Ex 2,500 15.12 37,812
2006-12-06 Doyle Thomas F (VP, General Counsel) Sale 7,000 15.00 104,979
2006-12-06 Doyle Thomas F (VP, General Counsel) Option Ex 7,000 13.00 91,000
2006-09-08 Leone John R (Director) Buy 4,000 12.27 49,064
2006-05-09 De Rosen Michel (Chief Executive Officer) Buy 10,100 9.84 99,333
2006-05-08 Claypool William D Md (Director) Buy 10,000 9.64 96,350
2006-02-28 Baker Felix (10% Owner) Sale 423,621 20.70 8,770,646
2006-02-27 Baker Felix (10% Owner) Sale 427,517 21.68 9,269,419
2005-06-13 Tarnoff Joshua M (VP, Commerical Opera) Buy 1,500 6.60 9,900
2005-06-10 Claypool William D Md (Director) Buy 10,000 5.75 57,500
2005-06-06 Glaser Robert (Director) Buy 12,500 5.48 68,475
2005-05-26 Claypool William D Md (Director) Buy 10,000 4.10 41,000
2005-05-26 Doyle Thomas F (VP, General Counsel) Buy 5,000 3.84 19,175
2005-05-19 Glaser Robert (Director) Buy 7,500 3.76 28,200
2005-05-12 De Rosen Michel (Chief Executive Officer) Buy 28,500 3.51 99,949
2005-05-11 Brooke Paul A (Director) Buy 126,500 3.12 394,806
2005-05-10 Baker Felix (Director) Buy 11,031 2.22 24,495
2005-05-06 Brooke Paul A (Director) Buy 33,500 2.47 82,778

Insider trading activities including stock purchases, stock sales, and option exercises of VPHM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viropharma Inc (symbol VPHM, CIK number 946840) see the Securities and Exchange Commission (SEC) website.